株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の医薬品市場:2012年までの予測

Global Pharmaceutical Market Forecast to 2012

発行 RNCOS E-Services Pvt. Ltd. 商品コード 146113
出版日 ページ情報 英文 190 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.58円で換算しております。
Back to Top
世界の医薬品市場:2012年までの予測 Global Pharmaceutical Market Forecast to 2012
出版日: 2011年02月01日 ページ情報: 英文 190 Pages
概要

世界における医薬品市場は、過去2年間の低迷後、現在は回復期に入っており、今後成長が見込まれています。景気低迷によるところが大きいものの、欧米など飽和する医薬品業界においてブロックバスター薬の特許失効も低迷の一因となりました。一方で、アジアやラテンアメリカなどの途上地域は引き続き安定した成長を見せています。全体として、市場は今後数年、好ましい成長が望める見込みです。

当レポートでは、世界の医薬品市場を地域別に調査し、各国(地域)の市場規模、需要、医療統計、将来の動向などを総合的に分析しており、概略以下の構成でお届けします。

第1章 アナリストの見解

第2章 世界の医薬品市場:概要

  • 市場規模と成長
  • 地域別実績
  • 主な治療クラス
  • 主な医薬品
  • 主要製薬企業

第3章 地域別市場

  • 北米
    • 米国
    • カナダ
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
    • チリ
  • 欧州
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • 英国
    • ロシア
    • トルコ
    • ポーランド
    • ハンガリー
    • ウクライナ
    • チェコ共和国
    • ルーマニア
  • アジア太平洋地域
    • インド
    • 中国
    • 日本
    • 韓国
    • インドネシア
    • ベトナム
    • タイ
    • フィリピン
    • マレーシア
    • オーストラリア
    • ニュージーランド
  • 中東・北アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • 南アフリカ
    • エジプト
    • ナイジェリア

第4章 主な企業

  • Pfizer Inc.
  • Sanofi-Aventis
  • GlaxoSmithKline
  • Novartis
  • AstraZeneca

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

The pharmaceutical market worldwide, after experiencing a slump during the past 2 years, is now in its recovery period, which will be followed by its growth. Decline in global pharma market was largely due to the economic slowdown, and further aggravated by patent expiry of key blockbusters together with saturation in key pharma markets, such as the US and Western Europe. Meanwhile, pharma markets in some developing regions, like Asia and Latin America have been continuously witnessing robust growth rate for the last few years on account of increasing prevalence of diseases, rising healthcare spending, and increasing affordability. Overall, these markets will enjoy good growth potential in coming few years.

According to our latest research “Global Pharmaceutical Market Forecast to 2012”, global pharma industry is projected to grow at a CAGR of around 6.5% during 2011-2013. The growth will be driven by low cost factor, increasing prevalence of diseases worldwide, and rising per capita income of consumers. Our research identifies that sales of generic drugs will emerge as the most prominent segment of the pharma market during the forecast period, indicating large opportunities for generics manufacturers to tap.

Our regional level analysis found that the pharma industry is growing at a rapid rate in emerging countries, such as India, China, Brazil, Russia, among others, while a slowdown in the growth has been encountered in the US and Western European countries. Besides, we have found that growing inorganically via means of mergers & acquisitions has emerged as the most viable way for the companies to expand/extend their reach at a faster rate and maintain their revenue. We anticipate this trend to continue in near future also.

“Global Pharmaceutical Market Forecast to 2012” provides a comprehensive analysis of every major pharmaceutical market worldwide. North America, Latin America, Europe, Asia-Pacific, and MENA have been selected as the most important regions to be discussed in this report. The report contains statistical and analytical information on each of these markets, covering their current market size, demand, and healthcare statistics. It also features analysis of future directions, supplemented with facts and figures.

Table of Contents

1. Analyst View

2. Global Pharmaceutical Market: An Overview

  • 2.1. Market Size & Growth
  • 2.2. Geographical Performance
  • 2.3. Leading Therapy Classes
  • 2.4. Leading Drugs
  • 2.5. Leading Pharmaceutical Companies

3. Market by Region

  • 3.1. North America
    • 3.1.1. US
    • 3.1.2. Canada
  • 3.2. Latin America
    • 3.2.1. Brazil
    • 3.2.2. Mexico
    • 3.2.3. Argentina
    • 3.2.4. Chile
  • 3.3. Europe
    • 3.3.1. Germany
    • 3.3.2. France
    • 3.3.3. Italy
    • 3.3.4. Spain
    • 3.3.5. UK
    • 3.3.6. Russia
    • 3.3.7. Turkey
    • 3.3.8. Poland
    • 3.3.9. Hungary
    • 3.3.10. Ukraine
    • 3.3.11. Czech Republic
    • 3.3.12. Romania
  • 3.4. Asia-Pacific
    • 3.4.1. India
    • 3.4.2. China
    • 3.4.3. Japan
    • 3.4.4. South Korea
    • 3.4.5. Indonesia
    • 3.4.6. Vietnam
    • 3.4.7. Thailand
    • 3.4.8. Philippines
    • 3.4.9. Malaysia
    • 3.4.10. Australia
    • 3.4.11. New Zealand
  • 3.5. MENA
    • 3.5.1. Saudi Arabia
    • 3.5.2. UAE
    • 3.5.3. South Africa
    • 3.5.4. Egypt
    • 3.5.5. Nigeria

4. Key Player Profiles

  • 4.1. Pfizer Inc.
  • 4.2. Sanofi-Aventis
  • 4.3. GlaxoSmithKline plc
  • 4.4. Novartis International AG
  • 4.5. AstraZeneca Plc

List of Figures:

  • Figure 2-1: Global - Pharmaceutical Market (Billion US$), 2008-2010
  • Figure 2-2: Global - Growth in Pharmaceutical Market (%), 2008-2010
  • Figure 2-3: Global - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
  • Figure 2-4: Global - Pharmaceutical Market by Region (%), 2009
  • Figure 2-5: Global - Revenue of Leading Pharmaceutical Companies (Billion US$), 2009
  • Figure 3-1: North America - Pharmaceutical Market (Billion US$), 2008-2010
  • Figure 3-2: North America - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
  • Figure 3-3: US - Pharmaceutical Market (Billion US$), 2008-2010
  • Figure 3-4: US - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
  • Figure 3-5: Canada - Pharmaceutical Market (Billion CAD), 2008-2010
  • Figure 3-6: Canada - Forecast for Pharmaceutical Market (Billion CAD), 2011-2013
  • Figure 3-7: Latin America - Pharmaceutical Market (Billion US$), 2008-2010
  • Figure 3-8: Latin America - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
  • Figure 3-9: Brazil - Pharmaceutical Market (Billion US$), 2008-2010
  • Figure 3-10: Brazil - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
  • Figure 3-11: Mexico - Pharmaceutical Market (Billion US$), 2008-2010
  • Figure 3-12: Mexico - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
  • Figure 3-13: Argentina - Pharmaceutical Market (Billion US$), 2008-2010
  • Figure 3-14: Argentina - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
  • Figure 3-15: Chile - Pharmaceutical Market (Million US$), 2008-2010
  • Figure 3-16: Chile - Forecast for Pharmaceutical Market (Million US$), 2011-2013
  • Figure 3-17: Europe - Pharmaceutical Market (Billion US$), 2008-2010
  • Figure 3-18: Europe - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
  • Figure 3-19: Germany - Pharmaceutical Market (Billion US$), 2009 & 2010
  • Figure 3-20: Germany - Share of Export in Pharmaceutical Market (2009)
  • Figure 3-21: Germany - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
  • Figure 3-22: France - Pharmaceutical Market (Billion Euro), 2008-2010
  • Figure 3-23: France - Share of Generics and Branded Drugs in Pharmaceutical Market (2009)
  • Figure 3-24: France - Forecast for Pharmaceutical Market (Billion Euro), 2011-2013
  • Figure 3-25: Italy - Pharmaceutical Market (Billion Euro), 2008-2010
  • Figure 3-26: Italy - Share of Prescription and Non-Prescription Drugs in Pharmaceutical Market (2009)
  • Figure 3-27: Italy - Forecast for Pharmaceutical Market (Billion Euro), 2011-2013
  • Figure 3-28: Spain - Pharmaceutical Market (Billion Euro), 2008-2010
  • Figure 3-29: Spain - Share of Prescription and OTC Drugs in Pharmaceutical Market (2010)
  • Figure 3-30: Spain - Forecast for Pharmaceutical Market (Billion Euro), 2011-2013
  • Figure 3-31: UK - Pharmaceutical Market (Billion US$), 2009 & 2010
  • Figure 3-32: UK - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
  • Figure 3-33: Russia - Pharmaceutical Market (Billion Rubles), 2008-2010
  • Figure 3-34: Russia - Share of Commercial and State Sector in Pharmaceutical Market (2009)
  • Figure 3-35: Russia - Share of Imported and Domestically-produced Drugs in Pharmaceutical Market
  • Figure 3-36: Russia - Forecast for Pharmaceutical Market (Billion Rubles), 2011-2013
  • Figure 3-37: Turkey - Pharmaceutical Market (Billion US$), 2008-2010
  • Figure 3-38: Turkey - Share of Branded and Generic Drugs in Pharmaceutical Market (2009)
  • Figure 3-39: Turkey - Share of Therapy Areas in Pharmaceutical Market (2009)
  • Figure 3-40: Turkey - Share of Imported and Domestically-produced Drugs in Pharmaceutical Market (2009)
  • Figure 3-41: Turkey - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
  • Figure 3-42: Poland - Pharmaceutical Market (Billion PLN), 2008-2010
  • Figure 3-43: Poland - Forecast for Pharmaceutical Market (Billion PLN), 2011-2013
  • Figure 3-44: Hungary - Pharmaceutical Market (Billion US$), 2008-2010
  • Figure 3-45: Hungary - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
  • Figure 3-46: Ukraine - Pharmaceutical Market (Billion US$), 2008-2010
  • Figure 3-47: Ukraine - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
  • Figure 3-48: Czech Republic - Pharmaceutical Market (Billion US$), 2008-2010
  • Figure 3-49: Czech Republic - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
  • Figure 3-50: Romania - Pharmaceutical Market (Billion US$), 2008-2010
  • Figure 3-51: Romania - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
  • Figure 3-52: Asia-Pacific - Pharmaceutical Market (Billion US$), 2009 & 2010
  • Figure 3-53: Asia-Pacific - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
  • Figure 3-54: India - Pharmaceutical Market (Billion US$), 2008-2010
  • Figure 3-55: India - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
  • Figure 3-56: China - Pharmaceutical Market (Billion US$), 2009 & 2010
  • Figure 3-57: China - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
  • Figure 3-58: Japan - Pharmaceutical Market (Trillion JPY), 2008-2010
  • Figure 3-59: Japan - Forecast for Pharmaceutical Market (Trillion JPY), 2011-2013
  • Figure 3-60: South Korea - Pharmaceutical Market (Billion US$), 2009 & 2010
  • Figure 3-61: South Korea - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
  • Figure 3-62: Indonesia - Pharmaceutical Market (Billion US$), 2008-2010
  • Figure 3-63: Indonesia - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
  • Figure 3-64: Vietnam - Pharmaceutical Market (Billion US$), 2008-2010
  • Figure 3-65: Vietnam - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
  • Figure 3-66: Thailand - Pharmaceutical Market (Billion US$), 2008-2010
  • Figure 3-67: Thailand - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
  • Figure 3-68: Philippines - Pharmaceutical Market (Billion US$), 2009 & 2010
  • Figure 3-69: Philippines - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
  • Figure 3-70: Malaysia - Pharmaceutical Market (Billion US$), 2009 & 2010
  • Figure 3-71: Malaysia - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
  • Figure 3-72: Australia - Pharmaceutical Market (Billion US$), 2009 & 2010
  • Figure 3-73: Australia - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
  • Figure 3-74: New Zealand - Pharmaceutical Market (Million US$), 2009 & 2010
  • Figure 3-75: New Zealand - Forecast for Pharmaceutical Market (Million US$), 2011-2013
  • Figure 3-76: Saudi Arabia - Pharmaceutical Market (Billion US$), 2008-2010
  • Figure 3-77: Saudi Arabia - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
  • Figure 3-78: UAE - Pharmaceutical Market (Billion US$), 2009 & 2010
  • Figure 3-79: UAE - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
  • Figure 3-80: South Africa - Pharmaceutical Market (Billion US$), 2008-2010
  • Figure 3-81: South Africa - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
  • Figure 3-82: Egypt - Pharmaceutical Market (Billion US$), 2008-2010
  • Figure 3-83: Egypt - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
  • Figure 3-84: Nigeria - Pharmaceutical Market (Million US$), 2009 & 2010
  • Figure 3-85: Nigeria - Forecast for Pharmaceutical Market (Million US$), 2011-2013

List of Tables:

  • Table 2-1: Global - Pharmaceutical Market by Region (Billion US$), 2009
  • Table 2-2: Global - Leading Therapy Classes by Sales (Billion US$), 2009
  • Table 2-3: Global - Leading Drugs by Sales (Billion US$), 2009
  • Table 3-1: US - Healthcare Statistics (2008-2010)
  • Table 3-2: US - Forecast for Healthcare Statistics (2011-2013)
  • Table 3-3: Canada - Healthcare Statistics (2008-2010)
  • Table 3-4: Canada - Forecast for Healthcare Statistics (2011-2013)
  • Table 3-5: Brazil - Healthcare Statistics (2008-2010)
  • Table 3-6: Brazil - Forecast for Healthcare Statistics (2011-2013)
  • Table 3-7: Mexico - Healthcare Statistics (2008-2010)
  • Table 3-8: Mexico - Forecast for Healthcare Statistics (2011-2013)
  • Table 3-9: Argentina - Healthcare Statistics (2008-2010)
  • Table 3-10: Argentina - Forecast for Healthcare Statistics (2011-2013)
  • Table 3-11: Chile - Healthcare Statistics (2008-2010)
  • Table 3-12: Chile - Forecast for Healthcare Statistics (2011-2013)
  • Table 3-13: Germany - Healthcare Statistics (2008-2010)
  • Table 3-14: Germany - Forecast for Healthcare Statistics (2011-2013)
  • Table 3-15: France - Healthcare Statistics (2008-2010)
  • Table 3-16: France - Forecast for Healthcare Statistics (2011-2013)
  • Table 3-17: Italy - Healthcare Statistics (2008-2010)
  • Table 3-18: Italy - Forecast for Healthcare Statistics (2011-2013)
  • Table 3-19: Spain - Healthcare Statistics (2008-2010)
  • Table 3-20: Spain - Forecast for Healthcare Statistics (2011-2013)
  • Table 3-21: UK - Healthcare Statistics (2008-2010)
  • Table 3-22: UK - Forecast for Healthcare Statistics (2011-2013)
  • Table 3-23: Russia - Healthcare Statistics (2008-2010)
  • Table 3-24: Russia - Forecast for Healthcare Statistics (2011-2013)
  • Table 3-25: Turkey - Healthcare Statistics (2008-2010)
  • Table 3-26: Turkey - Forecast for Healthcare Statistics (2011-2013)
  • Table 3-27: Poland - Healthcare Statistics (2008-2010)
  • Table 3-28: Poland - Forecast for Healthcare Statistics (2011-2013)
  • Table 3-29: Hungary - Healthcare Statistics (2008-2010)
  • Table 3-30: Hungary - Forecast for Healthcare Statistics (2011-2013)
  • Table 3-31: Ukraine - Healthcare Statistics (2008-2010)
  • Table 3-32: Ukraine - Forecast for Healthcare Statistics (2011-2013)
  • Table 3-33: Czech Republic - Healthcare Statistics (2008-2010)
  • Table 3-34: Czech Republic - Forecast for Healthcare Statistics (2011-2013)
  • Table 3-35: Romania - Healthcare Statistics (2008-2010)
  • Table 3-36: Romania - Forecast for Healthcare Statistics (2011-2013)
  • Table 3-37: India - Healthcare Statistics (2008-2010)
  • Table 3-38: India - Forecast for Healthcare Statistics (2011-2013)
  • Table 3-39: China - Healthcare Statistics (2008-2010)
  • Table 3-40: China - Forecast for Healthcare Statistics (2011-2013)
  • Table 3-41: Japan - Healthcare Statistics (2008-2010)
  • Table 3-42: Japan - Forecast for Healthcare Statistics (2011-2013)
  • Table 3-43: South Korea - Healthcare Statistics (2008-2010)
  • Table 3-44: South Korea - Forecast for Healthcare Statistics (2011-2013)
  • Table 3-45: Indonesia - Healthcare Statistics (2008-2010)
  • Table 3-46: Indonesia - Forecast for Healthcare Statistics (2011-2013)
  • Table 3-47: Vietnam - Healthcare Statistics (2008-2010)
  • Table 3-48: Vietnam - Forecast for Healthcare Statistics (2011-2013)
  • Table 3-49: Thailand - Healthcare Statistics (2008-2010)
  • Table 3-50: Thailand - Forecast for Healthcare Statistics (2011-2013)
  • Table 3-51: Philippines - Healthcare Statistics (2008-2010)
  • Table 3-52: Philippines - Forecast for Healthcare Statistics (2011-2013)
  • Table 3-53: Malaysia - Healthcare Statistics (2008-2010)
  • Table 3-54: Malaysia - Forecast for Healthcare Statistics (2011-2013)
  • Table 3-55: Australia - Healthcare Statistics (2008-2010)
  • Table 3-56: Australia - Forecast for Healthcare Statistics (2011-2013)
  • Table 3-57: New Zealand - Healthcare Statistics (2008-2010)
  • Table 3-58: New Zealand - Forecast for Healthcare Statistics (2011-2013)
  • Table 3-59: Saudi Arabia - Healthcare Statistics (2008-2010)
  • Table 3-60: Saudi Arabia - Forecast for Healthcare Statistics (2011-2013)
  • Table 3-61: South Africa - Healthcare Statistics (2008-2010)
  • Table 3-62: South Africa - Forecast for Healthcare Statistics (2011-2013)
  • Table 3-63: Egypt - Healthcare Statistics (2008-2010)
  • Table 3-64: Egypt - Forecast for Healthcare Statistics (2011-2013)
  • Table 3-65: Nigeria - Healthcare Statistics (2008-2010)
  • Table 3-66: Nigeria - Forecast for Healthcare Statistics (2011-2013)
  • Table 4-1: Pfizer Inc - Strengths & Weaknesses
  • Table 4-2: Sanofi-Aventis - Strengths & Weaknesses
  • Table 4-3: GlaxoSmithKline plc - Strengths & Weaknesses
  • Table 4-4: Novartis International AG - Strengths & Weaknesses
  • Table 4-5: AstraZeneca Plc - Strengths & Weaknesses
Back to Top